CFEIY: AI 评分 50/100 — AI 分析 (4月 2026)

China Feihe Limited produces and sells infant milk formula and related nutritional products, primarily in Mainland China. The company utilizes a wide distribution network, including e-commerce platforms and offline retailers, to reach its customer base.

Key Facts: AI Score: 50/100 Sector: Consumer Defensive

公司概况

概要：

China Feihe Limited is a leading infant milk formula producer in China, offering a range of nutritional products through a widespread distribution network encompassing both online platforms and traditional retail outlets, positioning it within the competitive packaged foods sector.

CFEIY是做什么的？

Founded in 1962 and headquartered in Beijing, China Feihe Limited has grown to become a prominent player in the Chinese infant milk formula market. The company's core business revolves around the production and sale of infant milk formula products, catering primarily to the Mainland China market, with some presence in the United States. Over the years, China Feihe has expanded its product portfolio to include a variety of milk-based products, such as raw milk, adult milk powders, and liquid milk products. Additionally, the company offers health care products, soybean powder, goat milk powder, and nutritional supplements, including vitamins, minerals, and herbs. China Feihe distributes its products through an extensive network comprising distributors, e-commerce platforms like Tmall, JD.com, and Suning.com, its own website and mobile application (including WeChat), and approximately 2,000 offline customers with 110,000 retail points of sale as of December 31, 2021. This multi-channel approach allows the company to reach a broad customer base across different demographics and geographic locations within China.

CFEIY的投资论点是什么？

China Feihe Limited presents a compelling investment case based on its established market position in the Chinese infant milk formula industry and its extensive distribution network. With a P/E ratio of 11.61 and a profit margin of 13.6%, the company demonstrates solid profitability. A dividend yield of 7.25% offers an attractive return to investors. Growth catalysts include expanding product lines and increasing penetration in lower-tier cities. However, potential may be worth researching risks such as regulatory changes in the infant formula industry and competition from both domestic and international players. The company's beta of 0.56 suggests lower volatility compared to the overall market.

CFEIY在哪个行业运营？

China Feihe operates within the competitive packaged foods industry, specifically focusing on the infant milk formula market in China. This market is characterized by increasing demand due to rising disposable incomes and urbanization. However, it is also subject to stringent regulations and intense competition from both domestic and international brands. The industry is experiencing a trend towards premiumization, with consumers increasingly seeking high-quality and safe products. China Feihe's established brand and distribution network position it to capitalize on these trends.

Packaged Foods

Consumer Defensive

CFEIY有哪些增长机遇？

Expansion into Lower-Tier Cities: China Feihe has the opportunity to further penetrate lower-tier cities in China, where demand for infant milk formula is growing rapidly. These markets often have less competition from international brands, allowing Feihe to gain market share. By leveraging its existing distribution network and tailoring products to local preferences, Feihe can tap into this significant growth potential. The market size for infant milk formula in lower-tier cities is estimated to be substantial, with ongoing growth expected through 2030.
Product Innovation and Premiumization: The company can drive growth by introducing new and innovative products, particularly in the premium segment. Chinese consumers are increasingly willing to pay more for high-quality and safe infant milk formula. Feihe can invest in research and development to create products with enhanced nutritional benefits and unique formulations. The premium infant milk formula market is projected to continue its expansion, offering significant revenue opportunities for Feihe.
E-commerce Channel Expansion: China Feihe can further expand its presence on e-commerce platforms such as Tmall, JD.com, and its own online channels. Online sales of infant milk formula are growing rapidly in China, driven by convenience and accessibility. By optimizing its online marketing strategies and improving its online customer service, Feihe can capture a larger share of the online market. This channel offers a direct-to-consumer approach, enhancing brand engagement and customer loyalty.
International Market Expansion: While primarily focused on the Chinese market, China Feihe has the potential to expand its presence in other international markets, particularly in Southeast Asia and other regions with significant Chinese diaspora populations. By adapting its products to local tastes and regulations, Feihe can tap into new sources of revenue and diversify its geographic risk. The global infant milk formula market is substantial, offering long-term growth opportunities for Feihe.
Strategic Partnerships and Acquisitions: China Feihe can pursue strategic partnerships and acquisitions to expand its product portfolio, enhance its distribution network, and gain access to new technologies. Collaborating with other companies in the food and beverage industry can provide synergies and accelerate growth. Acquisitions can also help Feihe to consolidate its market position and gain access to new markets or product categories. These strategic moves can strengthen Feihe's competitive advantage and drive long-term value creation.

Market capitalization of $4.52 billion, reflecting its significant presence in the Chinese infant milk formula market.
P/E ratio of 11.61, indicating a potentially undervalued stock relative to its earnings.
Profit margin of 13.6%, showcasing the company's ability to generate profits from its sales.
Gross margin of 63.4%, highlighting efficient cost management in production and sales.
Dividend yield of 7.25%, providing a substantial income stream for investors.

CFEIY提供哪些产品和服务？

Produces and sells infant milk formula products.
Offers raw milk and adult milk powders.
Manufactures liquid milk products.
Provides health care products.
Produces soybean powder and goat milk powder.
Retails vitamins, minerals, herbs, and other nutritional supplements.

CFEIY如何赚钱？

Manufactures and distributes infant milk formula and related products.
Sells products through distributors, e-commerce platforms, and its own website and mobile application.
Operates a distribution network of offline customers with numerous retail points of sale.

Infants and young children requiring milk formula.
Parents and caregivers seeking nutritional products for their children.
Adults consuming milk powders and health supplements.

Established brand reputation in the Chinese infant milk formula market.
Extensive distribution network across online and offline channels.
Strong research and development capabilities for product innovation.
Scale of operations providing cost advantages.

什么因素可能推动CFEIY股价上涨？

Ongoing: Expansion into new geographic markets within China, particularly lower-tier cities, is expected to drive revenue growth.
Ongoing: Product innovation and the introduction of premium infant milk formula products cater to evolving consumer preferences.
Ongoing: Continued growth in e-commerce sales through platforms like Tmall and JD.com.
Upcoming: Potential strategic partnerships or acquisitions to expand product portfolio and market reach.
Upcoming: Regulatory approvals for new product formulations or market expansions.

CFEIY的主要风险是什么？

Ongoing: Intense competition from both domestic and international brands in the Chinese infant milk formula market.
Ongoing: Regulatory changes in China's infant milk formula industry could impact production and sales.
Potential: Fluctuations in raw material costs, such as milk powder and other ingredients, could affect profitability.
Potential: Food safety concerns and negative publicity could damage brand reputation and consumer trust.
Potential: Economic slowdown in China could reduce consumer spending on infant milk formula.

CFEIY的核心优势是什么？

Strong brand recognition in China.
Extensive distribution network.
Diverse product portfolio.
Established research and development capabilities.

CFEIY的劣势是什么？

Heavy reliance on the Chinese market.
Vulnerability to regulatory changes in China.
Exposure to fluctuations in raw material costs.
Limited international presence.

CFEIY有哪些机遇？

Expansion into lower-tier cities in China.
Product innovation and premiumization.
E-commerce channel expansion.
International market expansion.

CFEIY面临哪些威胁？

Intense competition from domestic and international brands.
Changing consumer preferences.
Food safety concerns.
Economic slowdown in China.

CFEIY的竞争对手是谁？

Combi Co Ltd — Focuses on baby and childcare products beyond just formula. — (CUYTF)
Emmi AG — Diversified dairy company with a global presence. — (EMLZF)
Groupe Poult SAS — Specializes in biscuits and other food products. — (GPAGF)
Kewpie Corp — Known for mayonnaise and other condiments, also baby food. — (KCDMF)
Kewpie Corp — Known for mayonnaise and other condiments, also baby food. — (KCDMY)

Key Metrics

MoonshotScore: 50/100

Company Profile

CEO: Youbin Leng
Headquarters: Beijing, CN
Employees: 9,590
Founded: 2020

AI Insight

AI analysis pending for CFEIY

ADR Level: 1
ADR Ratio: 1:1
Home Market Ticker: CFEI

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does China Feihe Limited do?

China Feihe Limited is primarily engaged in the production, marketing, and distribution of infant milk formula products. The company offers a range of nutritional products, including raw milk, adult milk powders, liquid milk products, health care products, soybean powder, and goat milk powder. It sells its products through various channels, including distributors, e-commerce platforms, and its own retail network, primarily targeting the Chinese market. China Feihe aims to provide high-quality and safe infant milk formula to meet the growing demand in China.

What do analysts say about CFEIY stock?

Analyst coverage of CFEIY is limited due to its OTC listing and ADR Level 1 status. However, the company's strong market position in China's infant milk formula market and its consistent profitability are generally viewed positively. Key valuation metrics to consider include the P/E ratio, profit margin, and dividend yield. Growth considerations include the company's expansion into lower-tier cities and its product innovation efforts. Investors should conduct their own due diligence and consider the risks associated with investing in OTC stocks.

What are the main risks for CFEIY?

The main risks for China Feihe Limited include intense competition in the Chinese infant milk formula market, regulatory changes in China, fluctuations in raw material costs, and potential food safety concerns. The company's reliance on the Chinese market also exposes it to economic slowdowns in China. Additionally, as an OTC-listed company, CFEIY faces risks related to limited financial disclosure, lower trading volumes, and potential price volatility. Investors should carefully consider these risks before investing in CFEIY.

How does China Feihe Limited manage supply chain and input cost risks?

China Feihe Limited manages supply chain and input cost risks through strategic sourcing, long-term contracts with suppliers, and diversification of its supply base. The company also invests in research and development to improve production efficiency and reduce reliance on specific raw materials. Additionally, Feihe employs hedging strategies to mitigate the impact of currency fluctuations and commodity price volatility. These measures aim to ensure a stable supply of raw materials and control production costs, protecting the company's profitability.

What is CFEIY's dividend and shareholder return track record?

China Feihe Limited has a history of paying dividends to shareholders, with a current dividend yield of 7.25%. The company's dividend payout ratio is a key metric to assess the sustainability of its dividend payments. While specific details on dividend growth history and share buyback programs are not available, the company's commitment to returning value to shareholders through dividends is a positive signal. Investors should monitor the company's financial performance and dividend policy to assess the long-term sustainability of its dividend payments.